Integrity Bio is a leader in protein formulation development. We help companies turn molecules into medicines by creating great formulations. Our contract development organization is focused on the formulation and GMP filling of biologics. We have formulated over 200 biologics including vaccines, antibodies, proteins, and peptides for more than 100 firms. Integrity specializes in hard-to-formulate products in liquid and lyophilized forms.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

RESEARCH

TURTLETREE LAUNCHES NEW RESEARCH AND DEVELOPMENT FACILITY IN GREATER SACRAMENTO

TurtleTree | October 04, 2021

news image

TurtleTree has officially opened its new R&D facility in California's state capital. Located in West Sacramento, this 24,000-square-foot building will house a world-class research hub showcasing the company's extensive array of innovations and cell-based technologies. Representing a milestone in TurtleTree's US-based expansion plans, the research facility will spur the development of precision fermentation technology currently used to produce valuable milk in...

Read More

INDUSTRIAL IMPACT

THINKCYTE'S SHARES APPLICATIONS OF GHOST CYTOMETRY WITH INDUSTRIAL AND ACADEMIC THOUGHT LEADERS

ThinkCyte Inc. | July 12, 2022

news image

ThinkCyte Inc., a biotechnology company pioneering novel cell analysis and sorting instruments, announced that applications of its Ghost Cytometry technology were presented at several leading industry meetings. In May, the company was selected to present applications of the platform to experts in drug discovery at the prestigious Keystone Symposia. The company was also selected to deliver a podium presentation at the 2022 International Association for the Advancement of Cytometry's annual me...

Read More

DIAGNOSTICS

AVANTOR® TO COLLABORATE WITH GEMINIBIO TO BRING CUSTOM HYDRATED SOLUTIONS AND CELL CULTURE MEDIA TO BIOPHARMA CUSTOMERS

Avantor | June 24, 2022

news image

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries has entered into an agreement with GeminiBio to deliver custom hydrated solutions and cell culture media to the biopharma industry. Custom hydrated solutions and cell culture media are critical components of the bioproduction workflow, especially for emerging modalities such as gene therapy. This c...

Read More

INDUSTRIAL IMPACT

BIOCONSORTIA SHOWCASES BREAKTHROUGH MICROBIAL PRODUCTS AND PIPELINE OF INNOVATION

BioConsortia, Inc. | September 05, 2022

news image

BioConsortia’s innovative microbial products and technical capabilities were on full display August 30th at its Davis, CA headquarters in an investor-focused Technology Showcase event. BioConsortia demonstrated rapid advancements in microbial product and pipeline developments for reducing nitrogen fertilizers, controlling soil pests and plant diseases for larger and better-quality crop yields, as well as protecting crops post-harvest to avoid food waste, while minimizing environmental impa...

Read More
news image

RESEARCH

TURTLETREE LAUNCHES NEW RESEARCH AND DEVELOPMENT FACILITY IN GREATER SACRAMENTO

TurtleTree | October 04, 2021

TurtleTree has officially opened its new R&D facility in California's state capital. Located in West Sacramento, this 24,000-square-foot building will house a world-class research hub showcasing the company's extensive array of innovations and cell-based technologies. Representing a milestone in TurtleTree's US-based expansion plans, the research facility will spur the development of precision fermentation technology currently used to produce valuable milk in...

Read More
news image

INDUSTRIAL IMPACT

THINKCYTE'S SHARES APPLICATIONS OF GHOST CYTOMETRY WITH INDUSTRIAL AND ACADEMIC THOUGHT LEADERS

ThinkCyte Inc. | July 12, 2022

ThinkCyte Inc., a biotechnology company pioneering novel cell analysis and sorting instruments, announced that applications of its Ghost Cytometry technology were presented at several leading industry meetings. In May, the company was selected to present applications of the platform to experts in drug discovery at the prestigious Keystone Symposia. The company was also selected to deliver a podium presentation at the 2022 International Association for the Advancement of Cytometry's annual me...

Read More
news image

DIAGNOSTICS

AVANTOR® TO COLLABORATE WITH GEMINIBIO TO BRING CUSTOM HYDRATED SOLUTIONS AND CELL CULTURE MEDIA TO BIOPHARMA CUSTOMERS

Avantor | June 24, 2022

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries has entered into an agreement with GeminiBio to deliver custom hydrated solutions and cell culture media to the biopharma industry. Custom hydrated solutions and cell culture media are critical components of the bioproduction workflow, especially for emerging modalities such as gene therapy. This c...

Read More
news image

INDUSTRIAL IMPACT

BIOCONSORTIA SHOWCASES BREAKTHROUGH MICROBIAL PRODUCTS AND PIPELINE OF INNOVATION

BioConsortia, Inc. | September 05, 2022

BioConsortia’s innovative microbial products and technical capabilities were on full display August 30th at its Davis, CA headquarters in an investor-focused Technology Showcase event. BioConsortia demonstrated rapid advancements in microbial product and pipeline developments for reducing nitrogen fertilizers, controlling soil pests and plant diseases for larger and better-quality crop yields, as well as protecting crops post-harvest to avoid food waste, while minimizing environmental impa...

Read More